# Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)

> **NCT02312687** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin, Inc.** · enrollment: 20 (actual)

## Conditions studied

- X-Linked Hypophosphatemia

## Interventions

- **BIOLOGICAL:** KRN23

## Key facts

- **NCT ID:** NCT02312687
- **Lead sponsor:** Kyowa Kirin, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-30
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-11-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02312687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02312687, "Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02312687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*